Nobuhiro Hiramoto

1.3k total citations
72 papers, 488 citations indexed

About

Nobuhiro Hiramoto is a scholar working on Hematology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Nobuhiro Hiramoto has authored 72 papers receiving a total of 488 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Hematology, 18 papers in Pathology and Forensic Medicine and 17 papers in Oncology. Recurrent topics in Nobuhiro Hiramoto's work include Hematopoietic Stem Cell Transplantation (22 papers), Lymphoma Diagnosis and Treatment (18 papers) and Chronic Lymphocytic Leukemia Research (11 papers). Nobuhiro Hiramoto is often cited by papers focused on Hematopoietic Stem Cell Transplantation (22 papers), Lymphoma Diagnosis and Treatment (18 papers) and Chronic Lymphocytic Leukemia Research (11 papers). Nobuhiro Hiramoto collaborates with scholars based in Japan, United States and United Kingdom. Nobuhiro Hiramoto's co-authors include Takayuki Ishikawa, Noboru Yonetani, Yukihiro Imai, Satoshi Yoshioka, Hisako Hashimoto, Yotaro Ochi, Morio Ueno, Shigeru Kinoshita, Yoshitaka Asakura and Takuya Yamashita and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Scientific Reports.

In The Last Decade

Nobuhiro Hiramoto

62 papers receiving 486 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nobuhiro Hiramoto Japan	13	151	123	111	95	90	72	488
Reiji Fukano Japan	15	159 1.1×	186 1.5×	217 2.0×	53 0.6×	100 1.1×	59	671
Manuel Guerreiro Spain	13	352 2.3×	152 1.2×	74 0.7×	54 0.6×	190 2.1×	58	691
Stephan Fuhrmann Germany	11	110 0.7×	134 1.1×	38 0.3×	55 0.6×	120 1.3×	18	398
Somanath Padhi India	11	53 0.4×	156 1.3×	59 0.5×	90 0.9×	82 0.9×	62	457
Mohamad Sobh France	14	131 0.9×	230 1.9×	68 0.6×	81 0.9×	102 1.1×	61	476
Jacques Trauet France	12	142 0.9×	143 1.2×	68 0.6×	53 0.6×	82 0.9×	22	663
Kathleen Gray United States	15	168 1.1×	98 0.8×	31 0.3×	27 0.3×	115 1.3×	33	539
Jolanda M. van Dieren Netherlands	16	114 0.8×	29 0.2×	79 0.7×	32 0.3×	113 1.3×	41	742
Rufei Lu United States	16	91 0.6×	76 0.6×	141 1.3×	78 0.8×	67 0.7×	24	874
Laurence Clément France	13	128 0.8×	167 1.4×	36 0.3×	39 0.4×	127 1.4×	34	432

Countries citing papers authored by Nobuhiro Hiramoto

Since Specialization

Citations

This map shows the geographic impact of Nobuhiro Hiramoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nobuhiro Hiramoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nobuhiro Hiramoto more than expected).

Fields of papers citing papers by Nobuhiro Hiramoto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nobuhiro Hiramoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nobuhiro Hiramoto. The network helps show where Nobuhiro Hiramoto may publish in the future.

Co-authorship network of co-authors of Nobuhiro Hiramoto

This figure shows the co-authorship network connecting the top 25 collaborators of Nobuhiro Hiramoto. A scholar is included among the top collaborators of Nobuhiro Hiramoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nobuhiro Hiramoto. Nobuhiro Hiramoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fujimoto, Ayumi, Kana Miyazaki, Kimikazu Yakushijin, et al.. (2025). Improved prognosis of advanced-stage extranodal NK/T-cell lymphoma: results of the NKEA-Next study. Leukemia. 39(4). 909–916. 1 indexed citations

Iwasaki, Makoto, Masahiro Hirayama, Koji Kawamura, et al.. (2025). Donor selection in T-cell-replete haploidentical donor peripheral blood stem cell transplantation. Leukemia. 39(4). 951–961. 1 indexed citations

Jo, Tomoyasu, Yu Akahoshi, Tadakazu Kondo, et al.. (2024). First complete remission favours haploidentical haematopoietic stem cell transplantation with post‐transplant cyclophosphamide over cord blood transplantation in acute lymphoblastic leukaemia. British Journal of Haematology. 204(5). 1913–1919. 2 indexed citations

Nakamae, Hirohisa, Eisei Kondo, Takahiro Fukuda, et al.. (2024). Peripheral blood stem cell transplantation using HLA-haploidentical donor with post-transplant cyclophosphamide versus HLA-matched sibling donor for lymphoma. Bone Marrow Transplantation. 59(5). 630–636. 1 indexed citations

Konuma, Takaaki, Kotaro Miyao, Hideki Nakasone, et al.. (2024). Allogeneic transplantation of bone marrow versus peripheral blood stem cells from HLA-identical sibling donors for hematological malignancies in 6064 adults from 2003 to 2020: different impacts on survival according to time period. Cytotherapy. 26(8). 910–920. 2 indexed citations

Imahashi, Nobuhiko, Naoki Kurita, Takaaki Konuma, et al.. (2023). Effect of Conditioning Regimens and Graft-versus-Host Disease Prophylaxis on the Outcomes of Umbilical Cord Blood Transplantation Performed with Cyclophosphamide/Total Body Irradiation-Based Regimens. Transplantation and Cellular Therapy. 30(3). 318.e1–318.e11.

Suzuki, Kazuhito, Yutaka Shimazu, Takashi Ikeda, et al.. (2023). Efficacy of Autologous Stem Cell Transplantation for Myeloma Patients with Suboptimal Response: A Multicenter Retrospective Analysis. Transplantation and Cellular Therapy. 29(11). 688.e1–688.e13. 3 indexed citations

Koh, Hideo, Takaaki Konuma, Yoshimitsu Shimomura, et al.. (2023). HLA-Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplantation Cyclophosphamide versus HLA-Matched Unrelated Donor Transplantation for Myelodysplastic Syndrome. Transplantation and Cellular Therapy. 30(3). 316.e1–316.e12. 1 indexed citations

Fuji, Shigeo, Junichi Sugita, Yuho Najima, et al.. (2023). Low‐ versus standard‐dose post‐transplant cyclophosphamide as GVHD prophylaxis for haploidentical transplantation. British Journal of Haematology. 204(3). 959–966. 6 indexed citations

10.

Shimomura, Yoshimitsu, Yuya Nagai, Nobuhiro Hiramoto, et al.. (2023). Efficacy of letermovir in HLA-haploidentical hematopoietic transplantation with posttransplant cyclophosphamide. International Journal of Hematology. 118(3). 347–354.

11.

Shimomura, Yoshimitsu, Sho Komukai, Tetsuhisa Kitamura, et al.. (2023). Effect of graft-versus-host disease on outcomes of HLA-haploidentical peripheral blood transplantation using post-transplant cyclophophamide. Bone Marrow Transplantation. 59(1). 66–75. 2 indexed citations

12.

Onishi, Yasushi, Takehiko Mori, Hirohito Yamazaki, et al.. (2023). Comparison of Haploidentical Stem Cell Transplantation with Post-Transplantation Cyclophosphamide versus Umbilical Cord Blood Transplantation in Adult Patients with Aplastic Anemia. Transplantation and Cellular Therapy. 29(12). 766.e1–766.e8. 2 indexed citations

13.

Irie, Kei, Nobuhiro Hiramoto, Hiroaki Ikesue, et al.. (2023). Safety and blood levels of daratumumab after switching from intravenous to subcutaneous administration in patients with multiple myeloma. Investigational New Drugs. 41(5). 761–767. 4 indexed citations

14.

Hamuro, Junji, Morio Ueno, Tomoko Fujita, et al.. (2022). Repressed miR-34a Expression Dictates the Cell Fate to Corneal Endothelium Failure. Investigative Ophthalmology & Visual Science. 63(4). 22–22. 9 indexed citations

15.

Ueno, Morio, Nobuhiro Hiramoto, Tomoko Fujita, et al.. (2022). Cellular Interplay Through Extracellular Vesicle miR-184 Alleviates Corneal Endothelium Degeneration. SHILAP Revista de lepidopterología. 2(4). 100212–100212. 10 indexed citations

16.

Matsumoto, Mayumi, et al.. (2013). THE ROLE OF THE APHERESIS NURSE IN THE TEAM HEALTH CARE. Japanese Journal of Transfusion and Cell Therapy. 59(1). 58–61. 2 indexed citations

17.

Fuji, Shigeo, Nobuhiro Hiramoto, Yoshitaka Asakura, et al.. (2013). Reduced-intensity conditioning regimen with low-dose ATG-F for unrelated bone marrow transplant is associated with lower non-relapse mortality than a regimen with low-dose TBI: a single-center retrospective analysis of 103 cases. International Journal of Hematology. 98(5). 608–614. 14 indexed citations

18.

Nomoto, Junko, Nobuhiro Hiramoto, Motohiro Kato, et al.. (2012). Deletion of the TNFAIP3/A20gene detected by FICTION analysis in classical Hodgkin lymphoma. BMC Cancer. 12(1). 457–457. 31 indexed citations

19.

Nomoto, Junko, Nobuhiro Hiramoto, Motohiro Kato, et al.. (2009). Detection of Loss of A20 Gene by FICTION in Hodgkin's Lymphoma Cases.. Blood. 114(22). 270–270. 2 indexed citations

20.

Ono, Makiko, Takuji Watanabe, Carlos Shimizu, et al.. (2008). Therapy-Related Acute Promyelocytic Leukemia Caused by Hormonal Therapy and Radiation in a Patient with Recurrent Breast Cancer. Japanese Journal of Clinical Oncology. 38(8). 567–570. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact